Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients With Unresectable Esophageal and Gastroesophageal Adenocarcinoma
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181d7776d
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2010
Authors
Publisher
Elsevier BV